From industry veterans in specialty pharmacy comes a new solution for manufacturers that keeps the patient’s best interest at the center of every transaction, and data analytics to establish the Economic and Clinical Value (ECV) of a product as the outcome.
For the most innovative biotherapies to reach successful maturity, manufacturers must secure channels of support that deliver uncompromised patient care and real-world outcomes data. CareMetx provides a portfolio of technology and patient-centric services that complement existing distribution programs or provide complete launch support to establish ECV and achieve market access and sustain patient access.